Gene expression profiles revealed that the activation of the NF–κB and/or JAK/STAT3 pathways are characteristics of EBV-positive DLBCL, even when compared with ABC type EBV-negative DLBCL [148,149]. Here, STAT3 is linked to diffuse large B-cell lymphoma.